AI that learns your uncertainty: a new way to diagnose skin cancer?
NCT ID NCT07468357
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a personalized AI model can help experienced dermatologists more accurately diagnose skin lesions like melanoma. Fifty board-certified dermatologists will use either a standard AI or a new model that adapts to their individual uncertainty. The goal is to see if the personalized AI reduces misdiagnoses and improves doctor confidence.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- AI decision support model
- What this could lead to
- If successful, this could lead to better human-AI teamwork in diagnosing skin cancer, reducing misdiagnoses and improving doctor confidence.
- What could go wrong
- This is a small, early-stage study with only 50 participants. The expected accuracy gains are small because the doctors are already highly skilled. The AI may not generalize to other settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Board certified dermatologists with clinical experience in dermoscopic diagnosis. Exclusion Criteria: * Doctors who have not yet finished their specialization and dermatologists. * Dermatologists without clinical experience in dermoscopic diagnosis.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Skin lesions are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.